Sunday, December 2, 2012

 1:00

Exhibits - Setup
1:00-5:00

Exhibitor Registration
1:00-5:00

Posters Set-up
1:00-5:00

6:30

World stem cell SUMMIT welcomE reception sponsored by the Business Development Board of Palm Beach County (by invitation only)
6:30-8:30

Monday, December 3, 2012 

 7:00

Registration Opens

 8:00

Welcome Overview/ Opening Remarks - Grand Ballroom
- Bernard Siegel, JD, Genetics Policy Institute
- Camillo Ricordi, MD , University of Miami
- Joshua Hare MD, FACC, FAHA - University of Miami
- Richard Jove, PhD, City of Hope
- Karl-Henrik Grinnemo, MD, Karolinska Institutet
- Norio Nakatsuji, PhD, Institute for Integrated Cell-Material Science (iCeMS)

 8:30

PLENARY KEYNOTE - Grand Ballroom
The Power of Patient Advocacy in the Life Sciences
8:30-9:00
- Bernard Siegel, JD, Genetics Policy Institute

 9:00

Plenary Keynote - Grand Ballroom
Stem Cells:  Battles, Breakthroughs, Myths and Medicines
9:00-9:30
- George Q. Daley, MD, PhD, HHMI/Children's Hospital

 9:30

Plenary Panel Discussion - Grand Ballroom
How Stem Cells are Transforming Medicine
9:30-10:30
- George Q. Daley, MD, PhD, HHMI/Children's Hospital - Moderator
- Joshua M. Hare, MD, FACC, FAHA, University of Miami Miller School of Medicine
- Curt I. Civin, MD, University of Maryland School of Medicine
- Sally Temple, PhD, Neural Stem Cell Institute

 10:30

Morning Break - Exhibit Hall Opens

 10:45

Plenary Keynote - Grand Ballroom
Stem-Cell Based Organ Replacement and Cell Therapy
10:45-11:30
- Paolo Macchiarini, MD, PhD, Karolinska Instituet

 11:30

Plenary Keynote - Grand Ballroom
11:30-12:00
The Next Mountain to Climb-Shifting the Global Research/Translation Funding Paradigm
- Robert Klein, JD, Chair Emeritus of the Governing Board, California Institute for Regenerative Medicine 

 12:00

Plenary Keynote - Grand Ballroom
12:00-12:30
The Federal Government's Commitment to Funding High Potential Stem Cell Research
- Sonia Skarlatos, PhD, FAHA, National Heart, Lung, and Blood Institute

 12:30

Conversations with Experts LUNCHEON
Exhibit Hall
12:30-2:30

ESCRO Workshop I: IRB, SCRO and ESCRO Workshop II: Meeting the Institutional Oversight Challenges of Stem Cell Research - Ballroom B
12:30-2:30
- Melinda Abelman, M.Sc, Partners Healthcare System
- Geoffrey Lomax DrPH., California Institute for Regenerative Medicine

 2:30

focus Sessions:

Stem Cell Science - Cancer - Grand Ballroom
Research Session
2:30-3:30
- Stephen D. Nimer, MD, University of Miami Health System - Moderator
- Ravi Bhatia, MD, City of Hope National Medical Center
- Curt I. Civin, MD, University of Maryland School of Medicine
- Tan A. Ince, MD, PhD, Miller School of Medicine, University of Miami

Stem Cells for Drug Discovery - Ballroom A
Commercialization/Reimbursement Session
2:30-3:30
- Chris Parker, Cellular Dynamics International - Moderator
- Devyn Smith, PhD, Pfizer Worldwide R&D
- Rachelle J. Sells Galvin, PhD, Lilly Research Labs
- Alain Vertes, PhD, London Business School 

Translational Studies – ALS, Parkinson's and other Neurological Diseases - Ballroom B
Translation/Patient Advocacy Session
2:30-3:30
- Arlene Y. Chiu, PhD, Beckman Research Institute at City of Hope - Moderator
- Jeffrey D. Rothstein, MD, PhD, Johns Hopkins University School of Medicine
- Stephen Byer, Founder and Co-Executive Director, ALS WORLDWIDE
- Lucie Bruijn, PhD, Chief Scientist, The ALS Association
- Dennis Steindler, PhD, University of Florida

The Role of States in Regulating Stem Cell Therapies - Ballroom C
Translation/Regulatory Session
2:30-3:30
- Kirstin RW Matthews, PhD Rice University - Moderator
- Mitchell S. Fuerst, Esq. Fuerst Ittleman, PL
- Leigh Turner, PhD, University of Minnesota
- Keri Kimler, Texas Heart Institute

Translational Studies - Diabetes Progress Report - Room 2A
Translation/Commercialization Session
2:30-3:30
- Camillo Ricordi, MD, Diabetes Research Institute
- Juan Dominguez-Bendala, MSc, PhD, Diabetes Research Institute
- Karen Segal, PhD, Mesoblast, Inc
- Eugene P. Brandon, PhD, Viacyte

Stem Cell Progress Report - HIV/AIDS - Room 2B
Research/Translation Session
2:30-3:30
- Dan S. Kaufman, University of Minnesota - Moderator
- Joumana Zeidan, PhD, Vaccine & Gene Therapy Institute of Florida (VGTI-Florida)
- Jeffrey S. Bartlett, PhD, Calimmune, Inc.

Navigating the Landscape of Intellectual Property Law:  A Training Session for Businesspeople
and Scientists in Regenerative Medicine - Room 2C
Translation/Commercialization Session
2:30-3:30
- S. Peter Ludwig, Fish and Richardson - Moderator
- Nicholas A. Zachariades, PhD, Duane Morris, LLP
- Sam Woodley, Fish and Richardson
- David Smith, Pepper Hamilton, LLP

Stem Cells and the Senses--Vision, Hearing, Smell and Taste -Room 2D
Research/Translation Session
2:30-3:30
- Sally Temple, PhD, Neural Stem Cell Institute - Moderator
- Jeffery L. Goldberg, MD, PhD, University of Miami Miller School of Medicine
- Bradley J. Goldstein, MD, PhD, FACS, University of Miami Miller School of Medicine
- Nirupa Chaudhari, PhD, University of Miami School of Medicine

 3:30 

Afternoon Break - Exhibit Hall

 4:00

Concurrent Sessions:

Translational Studies - Cardiac - Grand Ballroom
Research/ Translation Session
4:00-5:00
- Joshua M. Hare, MD, FACC, FAHA, University of Miami Miller School of Medicine
- Alan W. Heldman, MD, FSCAI University of Miami Miller School of Medicine
- Jianyi (Jay) Zhang, MD, PhD University of Minnesota Medical School
- Leslie Miller, PhD, University of South Florida

The Outlook for Cord Blood - All Things Considered - Ballroom A
Translation/Commercialization Session
4:00-5:00
- Gregory A. Bonfiglio, Proteus Venture Partners - Moderator
- G. Rasul Chaudhry, Oakland University
- Calvin Cole, StemCyte North America
- Amnon Pelz, Taburit

Regulation of Cell-Based Therapies - A Global Overview - Ballroom B
Translation/Regulatory Session
4:00-5:00
- Scott Burger, Advanced Cell & Gene Therapy, LLC - Moderator
- Ken Kleinhenz, Cytori Therapeutics
- Steven S. Oh, PhD, Food and Drug Administration
- Tania Bubela, BSc (Hons), PhD, JD, University of Alberta

Understanding the Legal and Policy Challenges to Stem Cell Research - Ballroom C
Advocacy/ Consumer Safety Session
4:00-5:00
- Alan Jakimo, Sidley Austin, LLP - Moderator
- Jeanne F. Loring, PhD, The Scripps Research Institute
- Beth E. Roxland, JD, M.Bioethics, Hofstra University Bioethic Center
- Matthew Vincent, PhD, Advanced Cell Technology, Inc.

5:00

EXHIBITOR NETWORKING RECEPTION & Poster viewing WITH PRESENTERS PRESENT
Exhibit Hall
5:00-7:00

5:30

FLORIDA CONSORTIUM FOR REGENERATIVE MEDICINE
Room 1L
5:30-7:00

Tuesday, December 4, 2012 

 7:15

Registration Opens

 7:15

Networking Breakfast - Exhibit Hall

 8:15

welcome Remarks - Grand Ballroom
8:15-8:30
- Bernard Siegel, JD, Genetics Policy Institute
 

 8:30

Plenary Keynote
Filling an Unmet Need:  How the NIH Center for Regenerative Medicine
Advances the Field - Grand Ballroom
- Joshua Hunsberger, PhD, NIH Center for Regenerative Medicine
8:30-9:00

 9:00

Plenary Discussion
Unproven Stem Cell Therapies and Deceptive Claims: 
Hidden Dangers to Patients - Grand Ballroom
9:00-10:00
- Ann Tsukamoto, PhD,  StemCells, Inc. - Moderator
- Douglas A. Sipp, RIKEN Center for Developmental Biology
- Allan Wu, MD, Morrow Institute
- James Guest MD, PhD, FACS, University of Miami Miller School of Medicine

 10:00

Morning Break

 10:30

Concurrent Sessions:

Unleashing Regenerative Medicine to Extend the Healthy Lifespan: Technological Issues
and Commercial Opportunities  - Grand Ballroom
Translation/Commercialization Session
10:30-12:00
- Aubrey de Grey, PhD, SENS Research Foundation - Moderator
- Graca Almeida-Porada, MD, PhD, Wake Forest Institute for Regenerative Medicine
- Xianmin Zeng, PhD, Buck Institute for Research on Aging
- Jonathan L. Tilly, PhD, Harvard Stem Cell Institute

Reimbursement and Insurance Solutions for Cell Therapies and Related Industries - Ballroom A
Commercialization/ Reimbursement Session
10:30-12:00
- Dr. Catherine Prescott, Biolatris - Moderator
- Margaret Piper, PhD, Blue Cross Blue Shield Association
- Daniel Ryan, Swiss Re Services, Ltd.
- Richard Lewney, Cambridge Econometrics
- Geoff MacKay, Organogenesis, Inc.

Human Pluripotent Stem Cell Research (embryonic and reprogrammed) Discovering the Root Causes of Disease and Clinical Implications - Ballroom B
- Research Session
10:30-12:00
- Jeanne F. Loring, PhD, The Scripps Research Institute - Moderator
- Gary D. Smith, PhD, University of Michigan
- Outi Hovatta, MD, PhD, Karolinska Institutet
- Timothy J. Kamp MD, PhD, University of Wisconsin Medical School

Clinical Trial Update - Ballroom C
Translation / Regulatory Session
10:30-12:00
- Michael Werner, Holland and Knight - Moderator
- Ann Tsukamoto, PhD,  StemCells, Inc.
- Gil Van Bokkelen, PhD, Athersys, Inc.
- Gary Rabin, Advanced Cell Technology

 12:00

Exhibits Open - Exhibit Hall
Concessions available for purchase

 12:00

SYMPOSIA AND WORKSHOPS - POSTER SESSIONS WITH PRESENTERS PRESENT

INTERNATIONAL Symposium
Bridging Industry and Academia: The Vanguard of Stem Cell
Research and Application in Japan - Grand Ballroom
12:00-1:30
- Norio Nakatsuji, PhD, Institute for Integrated Cell-Material Science (iCeMS)
- Yasuhiko Tabata, PhD, D.Med. Sc., D. Pharm., Institute for Frontier Medical Sciences, Kyoto University
- Wado Akamatsu , MD, PhD, School of Medicine, Keio University
- Kenji Kawabata, PhD, National Institute of Biomedical Innovation (NIBIO)
- Chikafumi Yokoyama, PhD, ReproCELL, Inc.
- Masaaki Toyoda, PhD, Sumitomo Bakelite Co., Ltd
- Harumi  Ginya,  PhD, Genetein Co., Ltd.
- Masanari Kitagawa, PhD, Takara Bio Inc.
.
Box Lunch available for those who pre-registered.

What Philanthropists Need to Know - Ballroom A
12:00-1:30
- Robert A. Pearlman, Diabetes Research Institute Foundation, Inc. - Moderator
- Malin Burnham, Cushman & Wakefield
- William Haseltine, PhD, William A. Haseltine Foundation for Medical Sciences and the Arts
- Brock C. Reeve, Harvard Stem Cell Institute
Box Lunch available for those who pre-registered.

ESCRO Workshop II: IRB, SCRO and ESCRO Workshop II: Meeting the Institutional Oversight Challenges of Stem Cell Research - Ballroom B
12:00-1:30
- Melinda Abelman, M.Sc, Partners Healthcare System
- Geoffrey Lomax DrPH., California Institute for Regenerative Medicine
Box Lunch available for those who pre-registered.

 1:30

Concurrent Sessions:

Safety Issues in Stem Cell Therapies: Immunogenicity, Tumorgenicity,
and Genetic Stability - Grand Ballroom
Research / Translation Session
1:30-2:30
- Scott Burger, Advanced Cell & Gene Therapy, LLC - Moderator
- Joseph C. Wu, MD, PhD-Stanford
- Karen Aboody, PhD, City of Hope Beckman Research Institute

Stem Cell Politics: The Post-Election Advocacy Agenda - Ballroom A
Advocacy Session
1:30-2:30
- Bernard Siegel, Genetics Policy Institute - Moderator
- Amy Comstock Rick, Parkinson's Action Network and CAMR
- Paul S. Knoepfler, PhD, UC Davis School of Medicine
- Don Reed, Americans for Cures Foundation

Developing Combination Products: Cells, Genes, and Devices - Ballroom B
Translation / Regulatory Session
1:30-2:30
- Chris Mason, MBBS, PhD, FSB, FRCSI, FRCS, University College of London
- Michael D. West, PhD, BioTime, Inc.
- Steven S. Oh, PhD, Food and Drug Administration (FDA)

How Institutions Leverage Success Through Innovative Collaborations - Ballroom C
Translation/ Regulatory Session
1:30-2:30
- Richard Jove, PhD, Beckman Research Institute at City of Hope - Moderator
- Karl-Henrik Grinnemo, MD, Karolinska Institutet
- Mardi de Veuve Alexis, Beckman Research Institute at City of Hope
- Emeli Lundstrom, PhD, Karolinska Institutet
- Annika Thoresson, M.Sc, Karolinska University Hospital

 2:30

focus sessions

Strategies to Reverse Paralysis - Grand Ballroom
Translation/ Advocacy Session
2:30-3:30
- Xiao-Ming Xu, MD, PhD, University of Indiana School of Medicine - Moderator
- W. Dalton Dietrich, PhD, The Miami Project to Cure Paralysis
- Mark D. Noble, PhD, University of Rochester Medical Center
- Danny Heumann, JD, Heumannly Capable

Roadblocks to Translation - Effective Characterization, Cell Potency and
Validation of Research - Ballroom A
Translation/ Regulatory Session
2:30-3:30
- Scott Burger, Advanced Cell & Gene Therapy, LLC - Moderator
- Mark E. Brecher, MD, Laboratory Corporation of America
- Dr. Chris Burns, National Institute for Biological Standards and Control (NIBSC), United Kingdom
- Jessica Carmen, PhD, Lonza Walkersville, Inc.

Economic Development: Stem Cells and Regenerative Medicine as an
Engine for Economic Growth - Ballroom B
Translation / Regulatory Session
2:30-3:30
- Jonathan Thomas, PhD, JD, CIRM - Moderator
- Frank Stonebanks, Ontario Institute for Cancer Research
- Elona Baum, Esq. California Institute for Regenerative Medicine

Stem Cell Science - Bioengineering and Disease Correction - Ballroom C
Research Session
2:30-3:30
- Abner Mhashilkar, PhD, Wake Forest School of Medicine - Moderator
- Doris A. Taylor, PhD, FAHA, FACC Texas Heart Institute at St. Luke's Episcopal Hospital
- Mirjana Pavlovic, MD, PhD, Florida Atlantic University
- David Warburton, OBE, DSc, MD, MMM, FRCP, FRCS, FRCPCH, University of Southern California

Stirring Up the Hornet's Nest: Ethics and Stem Cell Research - Room 2A
Advocacy / Consumer Safety Session
2:30-3:30
- Robin N. Fiore, PhD, University of Miami - Moderator
- Kenneth W. Goodman, PhD, University of Miami
- William B. Hurlbut, MD, Stanford University
- Leigh Turner, PhD, University of Minnesota

Emerging Legal Issues for Regenerative Medicine Companies - Room 2B
Commercialiation / Reimbursement Session
2:30-3:30
- David S. Smith, Pepper Hamilton LLP - Moderator
- Gary Susser, Esq., The Law Offices of Gary Susser
- Michael J. Keller, Roetzel & Andress

Initial Funding Considerations: Strategies to Engage Private Equity - Room 2C
Commercialization / Reimbursement Session
2:30-3:30
- Jennifer S. Geetter, Esq. McDermott Will & Emery
- Arnold I. Caplan, PhD, Case Western Reserve University
- Mark C. Rogers, MD, MBA, Vestion, Inc.
- Ram Mandalam, PhD, Cellerant Therapeutics

 3:30

Break

 3:45

concurrent Sessions:

Taking Cell-Based Therapies to the Clinic, GMPs, GTPs, GCPs - Grand Ballroom
Translation / Regulatory Session
3:45-4:45
- Aisha Khan, Diabetes Research Institute - Moderator
- Larry A. Couture, PhD, Beckman Research Institute of City of Hope
- Bruce Levine, PhD., University of Pennsylvania School of Medicine
- Mark J. Tager MD, Stemedica Inc.

The Paradigm Shift to Cell Based Medicine: How Investors
Can Discern True Value - Ballroom A
- Commercialization / Reimbursement Session
3:45-4:45
- Jeffrey S. Cohen, Ladenburg Thalmann and Co. - Moderator
- Scott B. Livingston, Livingston Securities
- Robin R. Young, CFA, RRY Publications LLC

Stem Cells for Modeling Neurological Disorders - Ballroom B
Research Session
3:45-4:45
- Dileep R. Yavagal, MD, University of Miami Miller School of Medicine - Moderator
- Evan Y. Snyder, MD, PhD, F.A.A.P, Sanford-Burnham Medical Research Institute
- Joel C. Glover, PhD, University of Oslo

The Emergence of Academic Interdisciplinary Stem Cell Institutes as
Engines for Translational Progress - Ballroom C
Translation / Regulatory Session
3:45-4:45
- Timothy J. Kamp, MD, PhD, University of Wisconsin
- Brock C. Reeve, Harvard Stem Cell Institute
- Andre Terzic, MD, PhD, Professor of Medicine and Pharmacology, Mayo Clinic
- Paul S. Knoepfler, PhD, UC Davis School of Medicine

 4:45

Exhibitor Networking Reception and poster viewing With presenters present - Exhibit Hall
4:45-7:00

 6:30

Stem Cell Action Awards PRE-DINNER Reception sponsored by the Alliance for Regenerative Medicine (ARM), Athersys, Inc. and StemCells, Inc.
6:30-7:30

 7:30

Stem Cell Action Awards GALA Dinner
7:30-9:30
Pre-registration and ticket required

Wednesday, December 5, 2012

 8:00

Registration Opens

 8:00

Networking Breakfast - Exhibit Hall

 9:00

Plenary KEYNOTe
Patient Advocacy:  The Humanity Behind the Science - Grand Ballroom
9:00-9:30
- Grant Albrecht, 2011 Stem Cell Action Inspiration Award Honoree

9:30

PLENARY DISCUSSION
Leading Institutions and Their Strategies for Advancing
Regenerative Medicine - Grand Ballroom
9:30-11:00
- Rosario Isasi, McGill University - Moderator
- Prof. Dr. Frank Emmrich, University of Leipzig
- Dan Gincel, PhD, Maryland Stem Cell Research Fund
- Norio Nakatsuji, D.Sc., Kyoto University
- Timothy O'Brien, Regenerative Medicine Institute Ireland
- Susan Solomon, New York Stem Cell Foundation

 11:00

Morning Break

 11:30

focus Sessions:

New Discoveries: Stem Cells and Cardiovascular Disease - Grand Ballroom
Research / Translation Session
11:30-12:30
- Karl-Henrik Grinnemo, MD, Karolinska Instituet
- Carl J. Pepine, MD, MACC, University of Florida
- Clifford Folmes, PhD, Mayo Clinic

Emerging Trends in Bio Banking - Ballroom A
Translation / Regulatory Session
11:30-12:30
- Erik J. Forsberg, PhD, WiCell Research Institute - Moderator
- Glyn Stacey, PhD, UK Stem Cell Bank
- Karen M. Nichols, Esq. Rac, OvaScience, Inc.
- Roberto Waddington, CEO, CordVida, Brazil

Translational Studies - Cancer - Ballroom B
Research /Translation Session
11:30-12:30
- Tan A. Ince, MD, PhD, University of Miami - Moderator
- Cecilia Götherström, PhD, Karolinska University Hospital
- Eric Leire, MD, MBA, DanDrit Biotech A/S
- Brent A. Reynolds, PhD, University of Florida College of Medicine

Global Survey of Cell-Based Therapies - Ballroom C
Translation / Regulatory Session
11:30-12:30
- Kurt C. Gunter, MD, FASCP, International Society for Cell Therapy (ISCT) - Moderator
- Wise Young, MD, PhD, W.M. Keck Center for Collaborative Neuroscience
- Evan Snyder, PhD, Sanford-Burnham Medical Research Institute

The United States Military Investment in Regenerative Medicine - Room 2A
Translation / Regulatory Session
11:30-12:30
- Gil Van Bokkelen, PhD, Athersys
- Michael J. Yaszemski, MD, PhD, Mayo Clinic
- Michael Gilkey, MBA, MS, National Center for Regenerative Medicine

Endogenous Stem Cells - Research Update - Room 2B
Research Session
11:30-12:30
- James F. Eliason, PhD, Great Lakes Stem Cell Innovation Center - Moderator
- Donald G. Phinney, PhD, The Scripps Research Institute
- Benjamin Deverman, PhD, California Institute of Technology

 12:30

EXHIBITS OPEN - Exhibit Hall
Concessions available for purchase

 12:30

SYMPOSIA AND WORKSHOPS

Enabling Products & Technology Roundtable - Grand Ballroom
Translation / Commercialization Session
12:30-2:00 
- Claudia Zylberberg, PhD, Akron Biotech - Moderator
- Stefan Miltenyi, Miltenyi Biotec GmbH
- Mark L. Bonyhadi, PhD, Life Technologies Invitrogen
- Bruce C. Simpson, Fishers BioServices
Box Lunch available for those who pre-registered.

Financing Pathways for Stem Companies and Novel Funding Options - Ballroom A
Commercialiation Session
12:30-2:00
- Scott Burger, Advanced Cell & Gene Therapy, LLC - Moderator
- Robin L. Smith, MD, MBA, Neostem, Inc.
- David M. McGuigan, Stemedica Cell Technologies, Inc.
Box Lunch available for those who pre-registered.

ESCRO Workshop III:
IRB, SCRO and ESCRO Workshop II: Meeting the Institutional Oversight
Challenges of Stem Cell Research  - Ballroom B
12:30-2:00
- Melinda Abelman, M.Sc, Partners Healthcare System
- Geoffrey Lomax Dr.PH., California Institute for Regenerative Medicine
Box Lunch available for those who pre-registered.

 2:00

Concurrent Sessions:

New Stem Cell Discoveries - Clinical Implications  - Grand Ballroom
Research / Translation Session
2:00-3:00
- Chris Mason, MBBS, PhD, FSB, FRCSI, FRCS, University College of London - Moderator
- Annarosa Leri, PhD, Brigham and Women's Hospital
- Prof. Raphael Gorodetsky, PhD, Hadassah - Hebrew University Medical Center
- Martin Grumet, PhD, W.M. Keck Center for Collaborative Neuroscience

Public/Private Collaborations for Funding - Ballroom A
Translation / Regulatory session
2:00-3:00
- Michael H. May, PhD, Centre for Commercialization of Regenerative Medicine (CCRM) - Moderator
- Dr. Frank-Roman Lauter, Berlin-Brandenburg Center for Regenerative Therapies
- Robert Shaw, Stem Cell Initiative, EMD Milipore Corp
- Firman Ghouze, PhD, GE Healthcare

Cell Therapy & Pharmaceutical Industries - The Search for the Next New Thing - Ballroom B
Commercialization / Reimbursement Session
2:00-3:00
- Alain Vertes, PhD, London Business School - Moderator
- Michael Schuster, MS, MBA, Mesoblast
- Robert J. Hariri, MD, PhD, Celgene Cellular Therapeutics
- Edmund "Morrie" Ruffin, MA, Adjuvant Partners, LLC

Clinical Applications of Adipose (Fat) Derived Stem Cells - All Things Considered - Ballroom C
Advocacy / Consumer Safety Session
2:00-3:00
- Allan Wu, MD,  Morrow Institute - Moderator
- Douglas A. Sipp, Riken Center for Developmental Biology
- Ricardo Luis Rodriguez, MD, Johns Hopkins Medical School
- Joel Aronowitz, MD, Plastic Surgery

 3:00

Concurrent Sessions:

Tissue Engineering and Regenerative Medicine - Grand Ballroom
Research / Translation Session
3:00-4:00
- Abner Mhashilkar, PhD, Wake Forest School of Medicine - Moderator
- Anthony Windebank, MD, Professor of Medicine and Pharmacology, Mayo Clinic
- Ed Field, Cytomedix, Inc.

Promising Science from Industry Labs-selected company presentations - Ballroom A
Translation / Commercialization Session
3:00-4:00
- Claudia Zylberberg, PhD, Akron Biotech - Moderator
- Zami Aberman, Pluristem Therapeutics, Inc.
- Kenneth J. Livak, PhD, Fluidigm Corporation

Hospital and Clinical Perspectives on Stem Cells and Regenerative Medicine - Ballroom B
Translation/ Regulatory Session
3:00-4:00
- Thomas A. Gonwa. MD, FASN, Mayo Clinic - Moderator
- Professor Michael Whitaker,, FBiolSoc FMedSci, The Medical School, Newcastle University
- David Warburton, OBE, DSc, MD, MMM, FRCP, FRCS, FRCPCH, University of Southern California
- David Felten, MD, PhD, William Beaumont Hospital

 4:00

Break

 4:15

Plenary Discussion:
The Mandate to Deliver Cures- Aligning Patient Advocacy, Industry and Science - Grand Ballroom
4:15-5:15
- Bernard Siegel, JD, Genetics Policy Institute - Moderator
- Marion "Joe" Riggs, Student Society for Stem Cell Research
- Camillo Ricordi, MD, Diabetes Research Institute
- Alan Fernandez, Genetics Policy Institute

 5:15

stem cell ACTION town hall meeting - Grand Ballroom
5:15-6:00

 6:00

Closing Reception, Sponsored by GPI - Grand Ballroom/Terrace
6:00-6:30